Geode Capital Management’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.5M | Buy |
2,253,670
+298,165
| +15% | +$2.84M | ﹤0.01% | 1917 |
|
|
2025
Q1 | $20.5M | Buy |
1,955,505
+68,176
| +4% | +$713K | ﹤0.01% | 1888 |
|
|
2024
Q4 | $44.5M | Buy |
1,887,329
+27,916
| +2% | +$658K | ﹤0.01% | 1500 |
|
|
2024
Q3 | $66.8M | Buy |
1,859,413
+84,760
| +5% | +$3.05M | 0.01% | 1251 |
|
|
2024
Q2 | $62.6M | Buy |
1,774,653
+467,049
| +36% | +$16.5M | 0.01% | 1199 |
|
|
2024
Q1 | $37.1M | Buy |
1,307,604
+374,766
| +40% | +$10.6M | ﹤0.01% | 1557 |
|
|
2023
Q4 | $12.4M | Buy |
932,838
+75,128
| +9% | +$999K | ﹤0.01% | 2213 |
|
|
2023
Q3 | $7.69M | Buy |
857,710
+118,524
| +16% | +$1.06M | ﹤0.01% | 2415 |
|
|
2023
Q2 | $8.32M | Buy |
739,186
+170,664
| +30% | +$1.92M | ﹤0.01% | 2395 |
|
|
2023
Q1 | $6.55M | Buy |
568,522
+21,967
| +4% | +$253K | ﹤0.01% | 2506 |
|
|
2022
Q4 | $6.33M | Buy |
546,555
+12,938
| +2% | +$150K | ﹤0.01% | 2527 |
|
|
2022
Q3 | $6.78M | Buy |
533,617
+34,499
| +7% | +$438K | ﹤0.01% | 2502 |
|
|
2022
Q2 | $3.43M | Buy |
499,118
+10,316
| +2% | +$70.9K | ﹤0.01% | 2905 |
|
|
2022
Q1 | $4.71M | Buy |
488,802
+5,856
| +1% | +$56.5K | ﹤0.01% | 2827 |
|
|
2021
Q4 | $5.74M | Buy |
482,946
+67,422
| +16% | +$802K | ﹤0.01% | 2821 |
|
|
2021
Q3 | $6.75M | Buy |
415,524
+877
| +0.2% | +$14.2K | ﹤0.01% | 2733 |
|
|
2021
Q2 | $8.72M | Buy |
414,647
+123,751
| +43% | +$2.6M | ﹤0.01% | 2556 |
|
|
2021
Q1 | $4.52M | Buy |
290,896
+54,891
| +23% | +$852K | ﹤0.01% | 2841 |
|
|
2020
Q4 | $4.96M | Buy |
+236,005
| New | +$4.96M | ﹤0.01% | 2609 |
|